Search results
Author(s):
Mark Young Lee
,
Srinath Chilakamarri Yeshwant
,
Sreedivya Chava
,
et al
Added:
3 years ago
Aortic stenosis (AS) is the most common valvular heart disease in industrialised countries with a prevalence of about 5 % in the general population aged greater than 75 years. During the past decade, transcatheter aortic valve replacement (TAVR) has emerged as a valuable, minimally invasive treatment option for patients presenting with symptomatic severe AS, who due to their advanced age and…
View more
Author(s):
Robert Sheldon
Added:
5 years ago
ProfessorRobert S. Sheldon discusses arandomized pragmatic trial of strategies of permanent pacemaker versus implantable cardiac monitor in older patients with syncope and bifascicular block.
Filmed by Radcliffe Cardiology on-site at HRS 2018 in Boston, US.
View more
EPS in TAVI Patients
Author(s):
Oholi Tovia-Brodie
,
Yoav Michowitz
,
Bernard Belhassen
Added:
3 years ago
Article
Christoph Hammerstingl
Job title: Head of the department of Internal Medicine and Cardiology
Author
Ghada Mikhail
Research Area(s) / Expertise:
Job title: Consultant cardiologist
Author
Author(s):
Ana Paula Tagliari
,
Adriano Nunes Kochi
,
Bernardo Mastella
,
et al
Added:
3 years ago
Cardiac implantable electronic devices (CIEDs), including permanent pacemakers (PPMs), ICD and CRT devices, are the mainstream therapy for many potentially lethal heart conditions, such as advanced atrioventricular block or sustained ventricular tachycardia or fibrillation. CIEDs can be implanted through endovascular or epicardial routes, with the former used the most because it is less invasive…
View more
Author(s):
Rikke Esberg Kirkfeldt
,
Jens Brock Johansen
,
Jens Cosedis Nielsen
Added:
3 years ago
Cardiac implantable electronic device (CIED) therapy is effective and safe. However, infections related to CIED treatment may have devastating consequences, causing significant morbidity, mortality and generating considerable healthcare costs.1–6 Temporal trends in CIED treatment indicate a disproportional increase in CIED infections relative to implantation rates.1,7,8 Reasons for this trend are…
View more
Management of Cardiovascular Implantable Electronic Devices Infections in High-Risk Patients
Author(s):
Charles Kennergren
Added:
3 years ago
Article
Author(s):
Khaldoun G Tarakji
,
Christopher R Ellis
,
Pascal Defaye
,
et al
Added:
3 years ago
Over the last few decades an increasing body of evidence has supported the role of cardiovascular implantable electronic devices (CIEDs) including permanent pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT-D [with defibrillator] and CRT-P [without defibrillator]) in improving quality of life and survival.1 In addition, there has been a…
View more
Author(s):
Dhanunjaya Lakkireddy
Added:
2 years ago
In this interview, Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Overland Park, KS, US) discusses the outcomes of the multicenter Susruta-IST Registry, which aimed to report upon the outcomes of sinus node sparing surgical thoracoscopic hybrid ablation (SUSRUTA) for inappropriate sinus tachycardia (IST).
Questions:
1. Please summarise the aim, study design and endpoints?
2. What…
View more